| 2206135-30-8 | Palbociclib-012 | Palbociclib-012 |
| 2206135-48-8 | Quetiapine iMpurity | Quetiapine iMpurity |
| 2206135-50-2 | Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] | Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] |
| 2206230-32-0 | (R)-2-(4-Methylpiperazin-1-yl)propanoic acid hydrochloride | (R)-2-(4-Methylpiperazin-1-yl)propanoic acid hydrochloride |
| 2206265-54-3 | 1-(2-Fluoro-4-methylphenyl)-ethylamine hydrochloride | 1-(2-Fluoro-4-methylphenyl)-ethylamine hydrochloride |
| 2206320-30-9 | 2,4-Dichloro-6-ethoxyquinazoline | 2,4-Dichloro-6-ethoxyquinazoline |
| 2206360-62-3 | Levofloxacin Impurity 5 | Levofloxacin Impurity 5 |
| 2206360-74-7 | Rivaroxaban Impurity 35 | Rivaroxaban Impurity 35 |
| 2206360-84-9 | Rivaroxaban Impurity 49 | Rivaroxaban Impurity 49 |
| 2206568-00-3 | di-tert-butyl 1-(3-methylbenzyl)hydrazine-1,2-dicarboxylate* | di-tert-butyl 1-(3-methylbenzyl)hydrazine-1,2-dicarboxylate* |
| 2206606-86-0 | Aprepitant EP Impurity B | Aprepitant EP Impurity B |
| 2206606-97-3 | Ethanol, 2-[2-[4-(5,5-dioxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-oxido-1-piperazinyl]ethoxy]- | Ethanol, 2-[2-[4-(5,5-dioxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-oxido-1-piperazinyl]ethoxy]- |
| 2206608-00-4 | 1-(4-Chloro-2-fluorophenyl)-ethylamine hydrochloride | 1-(4-Chloro-2-fluorophenyl)-ethylamine hydrochloride |
| 2206608-25-3 | (S)-(tetrahydro-2H-pyran-2-yl)methanamine hydrochloride | (S)-(tetrahydro-2H-pyran-2-yl)methanamine hydrochloride |
| 2206609-91-6 | 1-[2-(Methylamino)ethyl]-4-piperidinol hydrochloride | 1-[2-(Methylamino)ethyl]-4-piperidinol hydrochloride |
| 2206610-58-2 | Tert-Butyl2,9-Diazaspiro[5.5]Undecane-9-Carboxylate Oxalate* | Tert-Butyl2,9-Diazaspiro[5.5]Undecane-9-Carboxylate Oxalate* |
| 2206610-69-5 | 1-oxa-8-azaspiro[4.5]decan-3-ol hydrochloride | 1-oxa-8-azaspiro[4.5]decan-3-ol hydrochloride |
| 2206677-06-5 | CAY10730 | CAY10730 |
| 2206677-82-7 | IDT-C8-2CHO | IDT-C8-2CHO |
| 2206735-61-5 | KRas G12C inhibitor 2 | KRas G12C inhibitor 2 |
| 2206735-75-1 | KRas G12C inhibitor 3 | KRas G12C inhibitor 3 |
| 2206736-04-9 | 2-((S)-1-acryloyl-4-(7-(8-methylnaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile | 2-((S)-1-acryloyl-4-(7-(8-methylnaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile |
| 2206736-07-2 | KRas G12C inhibitor 4 | KRas G12C inhibitor 4 |
| 2206737-02-0 | Pyrido[3,4-d]pyrimidine-7(6H)-carboxylic acid, 4-[(3S)-3-(cyanomethyl)-4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-5,8-dihydro-2-(methylthio)-, phenylmethyl ester | Pyrido[3,4-d]pyrimidine-7(6H)-carboxylic acid, 4-[(3S)-3-(cyanomethyl)-4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-5,8-dihydro-2-(methylthio)-, phenylmethyl ester |
| 2206737-03-1 | Pyrido[3,4-d]pyrimidine-7(6H)-carboxylic acid, 4-[(3S)-3-(cyanomethyl)-4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-5,8-dihydro-2-(methylsulfinyl)-, phenylmethyl ester | Pyrido[3,4-d]pyrimidine-7(6H)-carboxylic acid, 4-[(3S)-3-(cyanomethyl)-4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-5,8-dihydro-2-(methylsulfinyl)-, phenylmethyl ester |
| 2206737-05-3 | 1-Piperazinecarboxylic acid, 2-(cyanomethyl)-4-[5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester, (2S)- | 1-Piperazinecarboxylic acid, 2-(cyanomethyl)-4-[5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester, (2S)- |
| 2206737-06-4 | 2-Piperazineacetonitrile, 4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, (2S)- | 2-Piperazineacetonitrile, 4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, (2S)- |
| 2206737-78-0 | 2-Pyrrolidinemethanol, 4-fluoro-1-methyl-, (2S,4R)- | 2-Pyrrolidinemethanol, 4-fluoro-1-methyl-, (2S,4R)- |
| 2206741-04-8 | Naphthalene, 1-bromo-8-ethyl- | Naphthalene, 1-bromo-8-ethyl- |
| 2206741-25-3 | 2-Piperazinemethanol, 5-methyl-, (2R,5S)- | 2-Piperazinemethanol, 5-methyl-, (2R,5S)- |
| 2206741-27-5 | 1-Piperazinecarboxylic acid, 5-(hydroxymethyl)-2-methyl-, 1,1-dimethylethyl ester, (2S,5R)- | 1-Piperazinecarboxylic acid, 5-(hydroxymethyl)-2-methyl-, 1,1-dimethylethyl ester, (2S,5R)- |
| 2206742-47-2 | 4-Bromo-5,6-dimethyl-1H-indazole | 4-Bromo-5,6-dimethyl-1H-indazole |
| 2206742-48-3 | 4-Bromo-5,6-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole | 4-Bromo-5,6-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole |
| 2206788-99-8 | CCR4 antagonist 2 | CCR4 antagonist 2 |
| 2206792-50-7 | Sasanlimab | Sasanlimab |
| 2206821-02-3 | 2-Pyridinecarboxamide, 5,6-dichloro-N,N-dimethyl- | 2-Pyridinecarboxamide, 5,6-dichloro-N,N-dimethyl- |
| 2206825-58-1 | tert-butyl 7-oxo-1-azaspiro[4.4]nonane-1-carboxylate | tert-butyl 7-oxo-1-azaspiro[4.4]nonane-1-carboxylate |
| 2206825-81-0 | Apixaban Impurity 44 | Apixaban Impurity 44 |
| 2206825-87-6 | Apixaban Amino Acid Impurity | Apixaban Amino Acid Impurity |
| 2206825-95-6 | Levofloxacin Impurity 23 | Levofloxacin Impurity 23 |
| 2206826-82-4 | PraMipexole DiMer IMpurity II | PraMipexole DiMer IMpurity II |
| 2206827-12-3 | Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
| 2206827-14-5 | Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
| 2206970-15-0 | (3-Iodophenyl)acetic acid tert-butyl ester | (3-Iodophenyl)acetic acid tert-butyl ester |
| 2207524-70-5 | (3R)-3-Aminobutan-1-ol hydrochloride | (3R)-3-Aminobutan-1-ol hydrochloride |
| 2207528-55-8 | Ticagrelor Related Compound 93 | Ticagrelor Related Compound 93 |
| 2207541-23-7 | 2,6-Piperidinedione, 3-[1,3-dihydro-4-(4-hydroxy-1-butyn-1-yl)-1-oxo-2H-isoindol-2-yl]- | 2,6-Piperidinedione, 3-[1,3-dihydro-4-(4-hydroxy-1-butyn-1-yl)-1-oxo-2H-isoindol-2-yl]- |
| 2207541-30-6 | 2,6-Piperidinedione, 3-(1,3-dihydro-4-iodo-1-oxo-2H-isoindol-2-yl)- | 2,6-Piperidinedione, 3-(1,3-dihydro-4-iodo-1-oxo-2H-isoindol-2-yl)- |
| 2207569-08-0 | QCA570 | QCA570 |
| 2207590-51-8 | Ragifilimab | Ragifilimab |
| 2207596-93-6 | MPEG11-CH2CH2COONHS | MPEG11-CH2CH2COONHS |
| 2207600-84-6 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
| 2207601-04-3 | (3S,3'S)-3,3'-Bis(tert-butyl)-2,2',3,3'-tetrahydro-4,4'-bi-1,3-benzoxaphosphole | (3S,3'S)-3,3'-Bis(tert-butyl)-2,2',3,3'-tetrahydro-4,4'-bi-1,3-benzoxaphosphole |
| 2207601-10-1 | (2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole | (2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole |
| 2207601-12-3 | (2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole | (2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole |
| 2207870-15-1 | 5-Azaspiro[2.4]heptane-7-carboxylic acid, methyl ester, hydrochloride (1:1) | 5-Azaspiro[2.4]heptane-7-carboxylic acid, methyl ester, hydrochloride (1:1) |
| 2207960-17-4 | 1-(4-Methoxy-1-methyl-1H-pyrazol-3-yl)ethanol | 1-(4-Methoxy-1-methyl-1H-pyrazol-3-yl)ethanol |
| 2208138-72-9 | 2-Naphthalenecarbonitrile, 5-amino-5,6,7,8-tetrahydro-, hydrochloride (1:1), (5R)- | 2-Naphthalenecarbonitrile, 5-amino-5,6,7,8-tetrahydro-, hydrochloride (1:1), (5R)- |
| 2208275-54-9 | Apixaban Impurity 28 | Apixaban Impurity 28 |
| 2208275-99-2 | Aprepitant EP Impurity C | Aprepitant EP Impurity C |
| 2208746-53-4 | methyl3-(piperazin-1-yl)benzoatehydrochloride | methyl3-(piperazin-1-yl)benzoatehydrochloride |
| 2208779-90-0 | 1-(2-Fluoro-4-methylbenzyl)-piperazine dihydrochloride | 1-(2-Fluoro-4-methylbenzyl)-piperazine dihydrochloride |
| 2208780-63-4 | (S)-(-)-Ofloxacin-d3 (N-methyl-d3) | (S)-(-)-Ofloxacin-d3 (N-methyl-d3) |
| 2208821-82-1 | Ethyl 5-amino-4-chloro-2-nitrobenzoate | Ethyl 5-amino-4-chloro-2-nitrobenzoate |
| 2209040-18-4 | N,9,9-triphenyl-N-(4'-(triphenylsilyl)-[1,1'-biphenyl]-4-yl)-9H-fluoren-2-amine | N,9,9-triphenyl-N-(4'-(triphenylsilyl)-[1,1'-biphenyl]-4-yl)-9H-fluoren-2-amine |
| 2209045-57-6 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
| 2209053-93-8 | PDGFRα kinase inhibitor 1 | PDGFRα kinase inhibitor 1 |
| 2209078-25-9 | (S,E)-METHYL 2-AMINO-4-(4-FLUOROPHENYL)BUT-3-ENOATE HCL | (S,E)-METHYL 2-AMINO-4-(4-FLUOROPHENYL)BUT-3-ENOATE HCL |
| 2209082-58-4 | (2'-chloro-[1,1'-biphenyl]-2-yl)boronicacid | (2'-chloro-[1,1'-biphenyl]-2-yl)boronicacid |
| 2209085-22-1 | JH-XI-10-02 | JH-XI-10-02 |
| 2209085-45-8 | Urea, N-[3-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-3-oxopropyl]- | Urea, N-[3-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-3-oxopropyl]- |
| 2209086-92-8 | 1-((1S,2S)-2-(diMethylaMino)cyclohexyl)-3-(perfluorophenyl)thiourea | 1-((1S,2S)-2-(diMethylaMino)cyclohexyl)-3-(perfluorophenyl)thiourea |
| 2209087-06-7 | Bis(6-methylheptyl) Phthalate-3,4,5,6-d4 | Bis(6-methylheptyl) Phthalate-3,4,5,6-d4 |
| 2209087-17-0 | (2R)-2-[[[[3,5-
Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-
3,3-dimethyl-N-(phenylmethyl)butanamide | (2R)-2-[[[[3,5-
Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-
3,3-dimethyl-N-(phenylmethyl)butanamide |
| 2209090-37-7 | Thiophene, 5-bromo-3-fluoro-2-hexyl- | Thiophene, 5-bromo-3-fluoro-2-hexyl- |
| 2209109-64-6 | Stachartone A | Stachartone A |
| 2209112-05-8 | 6-(trifluoromethyl)-2-azaspiro[3.3]heptane hydrochloride | 6-(trifluoromethyl)-2-azaspiro[3.3]heptane hydrochloride |
| 2209112-96-7 | Amycolatopsin A | Amycolatopsin A |
| 2209112-97-8 | Amycolatopsin B | Amycolatopsin B |
| 2209833-23-6 | O-Allyl-L-Ser-HCl | O-Allyl-L-Ser-HCl |
| 2209881-38-7 | Spiro[benz[c]indeno[2,1-a]carbazole-14(13H),9'-[9H]fluorene] | Spiro[benz[c]indeno[2,1-a]carbazole-14(13H),9'-[9H]fluorene] |
| 2209911-80-6 | 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-, hydrochloride (1:1) | 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-, hydrochloride (1:1) |
| 2210228-45-6 | [1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]- | [1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]- |
| 2210228-73-0 | Bortezomib Impurity 60 | Bortezomib Impurity 60 |
| 2210244-83-8 | 9(10H)-Acridinone, 7-(2-aminoethyl)-1-fluoro- | 9(10H)-Acridinone, 7-(2-aminoethyl)-1-fluoro- |
| 2210247-59-7 | L-Alaninamide, N-[31-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1,29-dioxo-4,7,10,13,16,19,22,25-octaoxa-28-azahentriacont-1-yl]-L-valyl-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]- | L-Alaninamide, N-[31-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1,29-dioxo-4,7,10,13,16,19,22,25-octaoxa-28-azahentriacont-1-yl]-L-valyl-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]- |
| 2210254-25-2 | 1,3,2-Dioxaborolane, 2-(2'-chloro[1,1'-biphenyl]-2-yl)-4,4,5,5-tetramethyl- | 1,3,2-Dioxaborolane, 2-(2'-chloro[1,1'-biphenyl]-2-yl)-4,4,5,5-tetramethyl- |
| 2210262-72-7 | (2-chloronaphthalen-1-yl)boronic acid | (2-chloronaphthalen-1-yl)boronic acid |
| 2210266-88-7 | β-Alanine, N-[6-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-1-oxohexyl]-N-2-propyn-1-yl-, 1,1-dimethylethyl ester, rel- | β-Alanine, N-[6-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-1-oxohexyl]-N-2-propyn-1-yl-, 1,1-dimethylethyl ester, rel- |
| 2210266-91-2 | β-Alanine, N-[6-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-1-oxohexyl]-N-2-propyn-1-yl-, 2,5-dioxo-1-pyrrolidinyl ester, rel- | β-Alanine, N-[6-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-1-oxohexyl]-N-2-propyn-1-yl-, 2,5-dioxo-1-pyrrolidinyl ester, rel- |
| 2211054-17-8 | Macitentan Impurity 16 | Macitentan Impurity 16 |
| 2211054-46-3 | 4(3H)-Pyrimidinone, 6-amino-5-(4-bromophenyl)- | 4(3H)-Pyrimidinone, 6-amino-5-(4-bromophenyl)- |
| 2211054-90-7 | Macitentan Impurity 2 | Macitentan Impurity 2 |
| 2211057-81-5 | 4-Pyrimidinamine, 5-(4-bromophenyl)-6-chloro- | 4-Pyrimidinamine, 5-(4-bromophenyl)-6-chloro- |
| 2211059-00-4 | N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide | N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide |
| 2211059-05-9 | Macitentan Hydroxy amine Impurity | Macitentan Hydroxy amine Impurity |
| 2211060-61-4 | Antifungal agent 2 | Antifungal agent 2 |
| 2211082-53-8 | 1H-Pyrazole-4-carboxamide, 3-[2-(3,5-dimethoxyphenyl)ethynyl]-5-(methylamino)-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- | 1H-Pyrazole-4-carboxamide, 3-[2-(3,5-dimethoxyphenyl)ethynyl]-5-(methylamino)-1-[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]- |
| 2211097-75-3 | Acotiamide Impurity 21 | Acotiamide Impurity 21 |
| 2211174-73-9 | Thiol-PEG12-acid | Thiol-PEG12-acid |